Ardelyx's IPO

Ardelyx raised a round of funding on June 19, 2014. Investors include Public.

Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, non-systemic, small molecule therapeutics that work exclusively in the …

Articles about Ardelyx's IPO: